Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2003
11/13/2003US20030211577 Novel G protein-coupled receptor, GAVE7
11/13/2003US20030211576 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211575 Constituitively open voltage-gated kand methods for discovering modulators thereof
11/13/2003US20030211574 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptide; cancer diagnosis
11/13/2003US20030211573 Preparing glycoprotein in cells using enhanced carbamoyl-phosphate synthase II (CPS II)/aspartate transcarbamoylase (ATCase)/dihydro-orotase (CAD) enzyme; drug delivery and design
11/13/2003US20030211572 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptide; cancer diagnosis
11/13/2003US20030211571 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptide; cancer diagnosis
11/13/2003US20030211570 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211569 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211568 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2003US20030211567 Compositions, methods and systems for discovery of lipopeptides
11/13/2003US20030211560 Bioluminescent protease assay
11/13/2003US20030211559 Comprises composition for identifying therapeutic agents that inhibit proteolytic processing of amyloid precursor protein; treating nervous system disorders
11/13/2003US20030211549 Functional proteins and therapeutic and diagnostic methods for use thereof
11/13/2003US20030211546 Identifying bioactive agent/enzyme inhibitors capable of interfering with the binding of protein phosphatase 5 (PP5) to RAD protein; antitumor agents
11/13/2003US20030211541 Using immunological means to identify growth differentiation factor-14 (GDF-14) for treating cell proliferative and immunological disorders; gene expression inhibition; antiproliferative agents
11/13/2003US20030211540 Treatment of insulin resistance
11/13/2003US20030211538 CAP-Gly domain structure and uses thereof
11/13/2003US20030211537 Comprises nucleotide sequences coding membrane protein (MORD1) for screening and/or detection of opioid ligands; drug screening and design; analgesics; pain management
11/13/2003US20030211529 Human Eag2
11/13/2003US20030211525 Comprise nucleotide sequences coding cell cycle protein for use in diagnosis, prognosis and treatment of cancer and autoimmune diseases
11/13/2003US20030211521 Breast cancer antigen
11/13/2003US20030211520 Comprises urogenital system specific protein for diagnosing and treating tumors; antiproliferative agents; genetic vaccine
11/13/2003US20030211517 Comprises nucleotide sequences coding immunoglobulin protein for diagnosing and treating tumorous and nervous system disorders
11/13/2003US20030211515 Comprises nucleotide sequences coding matrix protein for diagnosing and treating cancer
11/13/2003US20030211514 Comprises nucleotide sequences coding polypeptide for use in diagnosis and treatment of neoplastic and neurodegenerative diseases
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211510 For stimulating and/or expanding T cells specific for lung tumors diagnosis, prevention and/or treatment of diseases, particularly lung cancer
11/13/2003US20030211509 Using extracellular signaling molecules to diagnose, prognosticate and treat septic shock, inflammation, and graft versus host disease
11/13/2003US20030211503 Using concentration of zinc finger protein (WT1) to detect cancer in children
11/13/2003US20030211493 Comprises membrane protein for diagnosis, prevention and treatment of infections, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
11/13/2003US20030211485 Novel proteins and nucleic acids encoding same
11/13/2003US20030211477 Carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) structure and uses thereof in drug identification and screening
11/13/2003US20030211476 Modulating protein expression/translation/concentration in cells; vaccine/drug delivery
11/13/2003US20030211472 125 human secreted proteins
11/13/2003US20030211467 Using monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy; genetic vaccine
11/13/2003US20030211465 Viricidal compound for prevention and treatment of human lymphadenopathy associated viral infection; immunotherapy
11/13/2003US20030211463 Monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy
11/13/2003US20030211453 Nucleotide sequences coding fertility associated antigen (FAA) for diagnosis and treatment of sexual or urogenital disorders
11/13/2003US20030211141 Genetic and protein manipulation of betaIG-H3 for the treatment and cure of muscular dystrophies
11/13/2003US20030211127 Controlled dissolution crosslinked prote in crystals
11/13/2003US20030211118 Immunizing compositions and methods of use
11/13/2003US20030211117 Synthetic antigen for the detection of aids-related disease
11/13/2003US20030211116 Polypeptide; anticancer agents; cytotoxic lymphocyte response
11/13/2003US20030211114 Vaccine for Pseudomonas aeruginosa
11/13/2003US20030211112 EGFR ligands and methods of use
11/13/2003US20030211101 Vascular endothelial growth factor-like protein from ORF viruses binds and activates mammalian VEGF receptor-2, and uses thereof
11/13/2003US20030211096 Detection of genes which amplification genome cells; anticancer, antitumor agent
11/13/2003US20030211092 Genetic engineering; gene expression; culture product
11/13/2003US20030211091 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2003US20030211089 Transgenic algae for delivering antigens to an animal
11/13/2003US20030211078 Therapy for restenosis; antiischemic agents; antitumor agents; anticancer agents; complexing
11/13/2003US20030211077 Stimulanting hematopoiesis
11/13/2003US20030211065 Alopecia; mutant gene
11/13/2003US20030211039 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
11/13/2003CA2763666A1 Keratinocytes expressing exogenous angiogenic growth factors
11/13/2003CA2489009A1 Connective tissue stimulating peptides
11/13/2003CA2485089A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/13/2003CA2484994A1 Peptide antagonists of tgf-beta family members and therapeutic uses thereof
11/13/2003CA2484920A1 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression
11/13/2003CA2484676A1 Kinase anchor protein muteins, peptides thereof, and related methods
11/13/2003CA2484538A1 Vectors with modified protease-dependent tropism
11/13/2003CA2484425A1 Fusions of cytokines and tumor targeting proteins
11/13/2003CA2484189A1 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003CA2484155A1 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
11/13/2003CA2483996A1 Promoters exhibiting endothelial cell specificity and methods of using same
11/13/2003CA2483912A1 Alcam and alcam modulators
11/13/2003CA2483909A1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003CA2483706A1 Genomic library of cyanophage s-2l and functional analysis
11/13/2003CA2483478A1 Factor vii or viia polypeptide variants
11/13/2003CA2483050A1 Optimization of transgene expression in mammalian cells
11/13/2003CA2483047A1 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants
11/13/2003CA2483038A1 Immunoglobulin-domain containing cell surface recognition molecules
11/13/2003CA2482810A1 Teneurin c-terminal associated peptides (tcap) and methods and uses thereof
11/13/2003CA2482411A1 Antibody fragments specific for human carncinoembryonic antigen (cea)
11/13/2003CA2480008A1 Use of il-13 receptor subunit alpha 2 as an anti-cancer vaccine
11/12/2003EP1361439A1 Screening for peptides inhibiting PP1c binding to Bcl-2, BCL-Xl and BCL-W proteins
11/12/2003EP1361433A2 Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
11/12/2003EP1361277A1 Optimization of transgene expression in mammalian cells
11/12/2003EP1361276A1 Pro-urokinase mutants
11/12/2003EP1361273A2 Interleukin-3 (IL-3) multiple mutation polypeptides
11/12/2003EP1361272A1 Neuritin, a neurogene
11/12/2003EP1361271A2 Isolated nonapeptide derived from MAGE-3 gene and presented by HLA-A1, and uses thereof
11/12/2003EP1361266A1 Transplantation cell kits for re-myelination in nerve cells
11/12/2003EP1360964A1 Use of galanin-like peptide
11/12/2003EP1360962A2 Interferon tau composition and methods of use
11/12/2003EP1360898A1 Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus
11/12/2003EP1360503A2 Modulators of p53-p300 interactions and screening methods therefor
11/12/2003EP1360500A2 Methods for selective targeting
11/12/2003EP1360496A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells
11/12/2003EP1360337A1 Ecteinascidin family compounds: compositions and methods
11/12/2003EP1360319A2 Diagnosis of diseases associated with metabolism
11/12/2003EP1360315A2 Antimicrobial methods and materials
11/12/2003EP1360314A2 Chemically defined medium for cultured mammalian cells
11/12/2003EP1360311A2 Membrane penetrating peptides and uses thereof
11/12/2003EP1360307A2 Chimeric polypeptides of serum albumin and uses related thereto
11/12/2003EP1360299A2 The genome of a bifidobacterium
11/12/2003EP1360298A2 Nucleotide sequences of the ribosomal protein s12 gene (rpsl) from corynebacterium glutamicum
11/12/2003EP1360297A2 Ragweed allergens
11/12/2003EP1360296A2 Method for the production of plant seed with modified fibre content and modified seed coat
1 ... 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 ... 2916